Finally, we also successfully translated our batch protocol to a fast and scalable continuous-flow process, which should enable a fast transition between medicinal and process chemistry (see GP7 described in the Supporting Information). In flow, we were able to prepare compounds 3, 49 and 50 in good yields requiring only 30 minutes of light exposure. We also exploited the continuous-flow technology to scale our benchmark reaction up to 5 mmol (78% isolated yield, Figure ), corresponding to a productivity of 21 g/d of compound 3.